[Drug-induced thrombocytopenia].
Higuchi
W
W
First Department of Internal Medicine, Niigata University School of Medicine.
Hattori
A
A
D000897:Anti-Ulcer Agents / Q000009:adverse effects; D000925:Anticoagulants / Q000009:adverse effects; D002511:Cephalosporins / Q000009:adverse effects; D006493:Heparin / Q000009:adverse effects; D006635:Histamine H2 Antagonists / Q000009:adverse effects*; D006801:Humans; D010406:Penicillins / Q000009:adverse effects; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects; D017713:Platelet Transfusion; D011379:Prognosis; D054328:Proton Pump Inhibitors; D013921:Thrombocytopenia / Q000139:chemically induced* / Q000628:therapy; D005719:gamma-Globulins / Q000008:administration & dosage
D000897:Anti-Ulcer Agents; D000925:Anticoagulants; D002511:Cephalosporins; D006635:Histamine H2 Antagonists; D010406:Penicillins; D010975:Platelet Aggregation Inhibitors; D054328:Proton Pump Inhibitors; D005719:gamma-Globulins; D006493:Heparin